Status:
COMPLETED
Pregnancy and Neonatal Follow-up of Ongoing Pregnancies Established in Clinical Trial 38833 (P05783)
Lead Sponsor:
Organon and Co
Conditions:
Pregnancy
Neonates
Eligibility:
FEMALE
18-39 years
Brief Summary
The objective of this trial is to evaluate whether corifollitropin alfa (MK-8962, Org 36286) treatment for the induction of multifollicular growth in women undergoing Controlled Ovarian Stimulation (C...
Detailed Description
This is a follow-up protocol to prospectively monitor pregnancy, delivery, and neonatal outcomes of all women who were treated with corifollitropin alfa and became pregnant during the base Trial 38833...
Eligibility Criteria
Inclusion
- Participants who received one dose of corifollitropin alfa in Trial 38833;
- Ongoing pregnancy confirmed by ultrasound at least 10 weeks after embryo transfer in Trial 38833;
- Able and willing to give written informed consent.
Exclusion
- None
Key Trial Info
Start Date :
April 1 2006
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
January 15 2008
Estimated Enrollment :
15 Patients enrolled
Trial Details
Trial ID
NCT00702520
Start Date
April 1 2006
End Date
January 15 2008
Last Update
September 5 2024
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.